|
GRANT AGENCY
|
GRANT´S
NUMBER
|
THE
GRANT´S NAME
|
SOLUTION TIME
|
GRANT´S
CO-ORDINATOR
|
GROUP
|
|
ME CR
|
OE08011
|
Superfine defined diets for
laboratory animals designed on natural components - development,
innovation,and plant tests
|
2008-2010
|
Pe. Dráber (M.
Boubelík) (co-investigator)
|
22
|
| EU FP6 |
018933 |
Clinigene European clinical Gene Transfer
Advisory Network |
2005-2011 |
J. Bubeník |
|
|
GA AS CR
|
IAA500520807
|
Mechanisms of protective
immunity against tumours with different expression of immunodulatory
molecules
|
2008-2010
|
M. Indrová
|
11
|
|
GSF
|
GA301/07/1410
|
Immunosuppressive
cell populations in the course of tumour progression and therapy.
|
2007-2011
|
M. Reiniš
|
11
|
|
GSF
|
GA301/09/1024
|
Molecular
and cellular mechanisms of tumour chemotherapy: immunomodulatory effects
|
2009-2011
|
M. Indrová
|
11
|
|
MZ ČR
|
NS10660_3/2009
|
Development of experimental
anti-WT 1 vaccine for immunotherapy of tumours
|
2009-2011
|
M. Indrová
(co-investigator)
|
11
|
|
GSF
|
P301/10/2174
|
Epigenetic mechanisms in
regulativ of genes important for antigen presentation and antitumour
immunity
|
2010-2013
|
M. Reiniš
|
11
|
|
EU
|
037377
|
Engineering of the porcine
genome for xenotransplantation studies in primates: a step towards
clinical application
|
2006-2011
|
J. Hejnar
|
12
|
|
GSF
|
GP204/08/P616
|
The role
of DNA methylation and histone modifications in the establishment and
maintenance of HIV-1 latency
|
2008-2010
|
J.
Blažková
|
12
|
|
GSF
|
GA301/09/P667
|
Transcriptional silencing of
retroviral vectors during their integration into the host genome
|
2009-2011
|
F. Šenigl
|
12
|
|
GSF
|
GA301/09/2031
|
Fuzogenic envelope glycoproteins of human endogenous
retroviruses and thein receptors
|
2009-2011
|
J. Hejnar
|
12
|
|
GSF
|
P502/10/1651
|
Characterization
of new avian sarcoma and leukosis virus (ASLV) receptor alleles as
revealed by the analysis of semiresistant cells
|
2010-2012
|
J. Plachý
|
12
|
|
GA AS CR
|
IAA500520707
|
The role of innate immune
molecules in embryonic homeostasis and sterile inflammation
|
2007-2011
|
D. Filipp
|
13
|
|
GSF
|
GA310/09/2084
|
Characterization
of the molecular machinery regulating the recruitment of signaling
molecules to lipid rafts
|
2009-2013
|
D. Filipp
|
13
|
|
ME CR
|
2B08066
|
Novel treatment of genetically
determined metabolic disease, type 1 diabetes, using an
immunotherapeutical approach.
|
2008-2011
|
D. Filipp
|
13
|
|
GA AS CR
|
IAA500390701
|
Role of proteins associated with
Cannabinoid receptor CB1 in trafficking
|
2007-2011
|
J. Blahoš
|
14
|
|
GA AS CR
|
IAA400400621
|
DNA Condensation: Monte-Carlo
Simulations, Light Scattering, Fluorescence Correlation Spectroscopy in
vitro and in vivo
|
2006-2010
|
J. Blahoš (co-ordinator)
|
14
|
|
GSF
|
GA303/08/1591
|
Study of
glutamate receptors conformational changes using novel fluorescent
techniques
|
2008-2012
|
J. Blahoš
|
14
|
|
GSF
|
GA310/08/1697
|
First genetic model for analysis
of susceptibility to parasite Leishmania tropica: potential
implications for studies of human leishmaniases
|
2008-2012
|
M. Lipoldová
|
15
|
|
ME CR
|
LC06009
|
Centre for molecular ecology of
vectors and pathogens
|
2006-2010
|
M. Lipoldová
|
15
|
|
AS CR
|
KAN200520801
|
Targeted expression and
transport of bioactive molecules
|
2008-2012
|
D. Staněk
|
16
|
|
GSF
|
P305/10/0424
|
Regulation
of alternative splicing via chromatin acetylation
|
2010-2013
|
D. Staněk
|
16
|
| EU FP6 |
LSHP-CT-2007-037693 |
HIV protease inhibitor resistance by
enzyme-substrate coevolution |
2007-2011 |
R. Sedláček |
|
|
GA AS CR
|
IAA500520812
|
Investigating the pathologic
role of metalloproteinases in liver using transgenic mice with
conditional expression of transgenes
|
2008-2012
|
R. Sedláček
|
18
|
|
GSF
|
GC301/08/J053
|
Mouse models for investigation
of biological functions of novel Kazal-type protease inhibitors LEKTI-2
and LEKTI-3
|
2008-2010
|
R. Sedláček
|
18
|
|
GSF
|
P305/10/2143
|
Generation of mouse models for
targeting stelete cells and myofibroblasts in the liver
|
2010-2013
|
R. Sedláček
|
18
|
|
GSF
|
P303/10/2044
|
The Impact of a liver-specific
deficiency of growth factor sheddase ADAM10 on liver development and
pathology
|
2010-2013
|
M. Jiroušková
|
18
|
|
AS CR
|
KAN200520804
|
Biocompatible nanofiber
scaffolds forming novel drug matrices for the application of
biologically and pharmacologically active substances
|
2008-2012
|
V. Holáň
|
19
|
|
EU – FP7
|
222509
|
KINACEPT-Novel anti-inflammatory
compounds for autoimmune diseases
|
2008-2010
|
V. Holáň (co-investigator)
|
19
|
|
GSF
|
GD310/08/H077
|
Regulation of immunological
mechanisms in health and disease:Development of new diagnostic and
therapeutic approaches
|
2008-2011
|
V. Holáň
(co-investigator.)
|
19
|
|
GSF
|
GA206/08/0640
|
Host-parasite
relationship, hybrid zone, immune systém, house mouse, Mus
musculus
|
2008-2012
|
V. Holáň (co-investigator)
|
19
|
|
GSF
|
GA204/07/1567
|
Tumor suppressors in the Wnt
signaling pathway
|
2007-2010
|
V. Kořínek
|
20
|
|
ME CR
|
2B06077
|
High throughput analysis of
chromatin structure for development of novel diagnostic and therapeutic
approaches in cancer
|
2006-2011
|
V. Kořínek
|
20
|
|
GSF
|
P305/10/1931
|
Identification
of interactors of the meiotic histone methyltransferase Hybrid
sterility 1 /PR-domain 9)
|
2010-2013
|
Z. Trachtulec
|
21
|
| EU FP6 |
LSH-CT-2006-037627 |
AnEUploidy: understanding gene dosage
imbalance in human health using genetics, functional genomics and
system biology |
2006-2010 |
J.Forejt |
|
| AS CR |
Premium Academiae |
Premium Academiae |
2007-2013 |
J. Forejt |
|
|
AS CR
|
M200520901
|
Novel components of mast cell
immune receptor signalling
|
2009-2012
|
Pe. Dráber
|
22
|
|
AS CR
|
KAN200520701
|
Nano-PCR –
ultrasenzitivní test detekce specifických proteinů
v tělních tekutinách
|
2007-2011
|
Pe. Dráber
|
22
|
|
GSF
|
GA301/09/1826
|
Topography
and function of
Csk-binding proteins of the plasma membrane in
mast cells
|
2009-2013
|
Pe. Dráber
|
22
|
|
GSF
|
P302/10/1759
|
Function-structure relationships
between transmembrane adaptor-based signalosomes in mast cells
|
2010-2013
|
L. Dráberová
|
22
|
|
AS CR
|
KAN200520703
|
The use of ultrasound in
nanomedicine
|
2007-2011
|
L. Anděra (co-investigator)
|
23
|
|
MH CR
|
NS10287-3/2009
|
Experimental therapy of mantle
cell lymphoma (Mantle Cell Lymphoma, MCL)
|
2009-2011
|
L. Anděra (co-investigator)
|
23
|
|
GA AS CR
|
KJB500520801
|
Dissection of Bid function in
TRAIL-induced apoptosis
|
2008-2010
|
M. Koc
|
23
|
|
GSF
|
P301/10/1971
|
Expression,
signaling and function of Death Receptors in human embryonic stem cells
|
2010-2012
|
L. Anděra
|
23
|
|
GSF
|
MEM/09/E011
|
Signaling and
adaptor proteins of leukocyte membrane microdomains
|
2009-2012
|
V. Hořejší
|
24
|
|
ME CR
|
1M0506
|
Center of Molecular and Cellular
Immunology
|
2005-2011
|
V. Hořejší
|
24
|
|
ME CR
|
2B06064
|
New target genes for childhood
leukemia diagnosis and treatment focused on adaptor molecules of
signaling pathways
|
2006-2011
|
T. Brdička
|
24
|
|
AS CR
|
KAN200520704
|
New nanoparticles for
ultrastructural diagnostics
|
2007-2011
|
P. Hozák
|
25
|
|
GSF
|
GA204/07/1592
|
Functions of nuclear myosin in
gene expression
|
2007-2011
|
P. Hozák
|
25
|
|
GSF
|
GA204/09/H084
|
Molecular biology of a differentiating cell
|
2009-2012
|
P. Hozák
|
25
|
| ME CR |
LC545 |
Functional organisation of the cell |
2005-2010 |
P. Hozák |
|
| ME CR |
ME09101 |
Cooperative contribution of actin- and
myosin-families to the chromatin dynamics and tranion in the cell
nucleus |
2009-2010 |
P. Hozák |
|
|
ME CR
|
2B06063
|
Flurescence microscopy in
biological and medical research
|
2006-2011
|
P. Hozák
|
25
|
|
GSF
|
GA204/09/1777
|
Analysis of signaling assemblies
containing gamma-tubulin
|
2009-2011
|
Pa. Dráber
|
26
|
|
GSF
|
P302/10/1701
|
Analysis of functional
differences between gamma-tubulins
|
2010-2012
|
E. Dráberová
|
26
|
|
GSF
|
GA204/09/0085
|
RNA silencing and long dsRNA in
mammalian cells
|
2009-2013
|
P. Svoboda
|
28
|
|
ME CR
|
ME09039
|
Role of posttranslational
mechanisms in reprogramming mouse oocytes to pluripotent cells.
|
2009-2012
|
P. Svoboda
|
28
|
|
GSF
|
P305/10/2215
|
Control of chromatin and
pluripotency by microRNAs
|
2010-2013
|
P. Svoboda
|
28
|
|
GA AS CR
|
IAA500520604
|
Developmental Genetics of
Amphioxus:Insight into Evolutionary Origin of Vertebrates
|
2006-2010
|
Z. Kozmik
|
29
|
|
GA AS CR
|
IAA500520908
|
Význam genů Pax
v evoluci oka
|
2009-2013
|
Z. Kozmik
|
29
|
|
GSF
|
GD204/09/H058
|
Intercellular signalling in
development of the organism and in disease genesis
|
2009-2012
|
Z. Kozmik (co-investigator)
|
29
|
|
GSF
|
GA204/08/1618
|
Molecular basis of canonical Wnt
signalling during eye and brain development
|
2008-2010
|
Z. Kozmik
|
29
|
|
P305/10/J064 |
Reconstructing urbilaterian
photoreceptors: comparative study between Branchiostoma (Chordata) and
Platynereis (Annelida) |
2010-2012 |
Z. Kozmik (co-investigator) |
29 |
|
GSF
|
GA203/09/0820
|
Structurally
inspired synthese of the selectiv inhibitors nukleotidas, potentially
important medicals
|
2009-2013
|
J. Brynda
|
31
|
|
MIT
|
2A-2TP1/076
|
Generic therapeutic antibodies
|
2007-2011
|
J. Sedláček
|
31
|
| ME CR |
1M0505 |
Center of
targeted therapeutic drugs |
2005-2011 |
M. Fábry (co-investigator) |
31 |
|
ME CR
|
1M6837805002
|
Center for Applied Genomics
|
2005-2011
|
V. Pačes
|
33
|
|
ME CR
|
2B06106
|
Novel genomic and
biotechlological approaches in molecular oncology: a way to the early
diagnostics and targeted therapy
|
2006-2011
|
Č. Vlček
|
33
|
|
ME CR
|
2B08031
|
Metagenomics and bioinformatics as a basis for preparation of effective
approaches, preparation and characterization of microorganisms and their consortia for utilization in bioremediation
|
2008-2011
|
J. Pačes
|
33
|
|
GSF
|
P305/10/J052
|
Functional analysis of
endogenous retroviral elements in human genome: possible association
with cancers
|
2010-2012
|
J. Pačes
|
33
|
|
AS CR
|
KAN200200651
|
Nanoparticulate and
supramolecular systems for targeted drug delivery
|
2006-2010
|
J. Králová
(co-investigator)
|
36
|
|
GSF
|
GA203/09/1311
|
Synthetic probes for recognition
of tumor markers: applications for cell directed apoptosis and targeted
photodynamic therapy
|
2009-2012
|
J. Králová
|
36
|
|
GSF
|
GA301/09/1727
|
Large-scale
identification of genes responsible for the formation of solid tumours
|
2009-2012
|
M. Dvořák
|
36
|
|
ME CR
|
LC06061
|
Center of Cell Invasiveness in
Embryonic Development and Tumour Metastases
|
2006-2010
|
M. Dvořák
|
36
|
|
GSF
|
P305/10/2133
|
Studium
migrace satelitních buněk
|
2010-2012
|
P. Kašpar
|
36
|
|
GSF
|
GA204/08/1418
|
The role of the
JAK/STATsignalling pathway in cellular senescence
|
2008-2012
|
Z. Hodný
|
37
|
|
GSF
|
GA301/08/0353
|
Protein modifications in DNA
damage signalling: Mechanisms and cancer relevance
|
2008-2010
|
J. Bartek
|
37
|
| GSF |
P301/10/1525 |
Mechanisms of DNA damage checkpoint termination
|
2010-2012 |
J. Bartek |
|
|
GSF
|
GA204/08/1418
|
The role
of the JAK/STAT signalling pathway in cellular senescence
|
2008-2012
|
Z. Hodný
|
37
|
|
GSF
|
P305/10/P420
|
Role of Wip1 phosphatase in the
DNA damage response
|
2010-2012
|
L. Macůrek
|
37
|
|
FP7 EU
|
TRIREME 223575
|
Systems-Level,
Multi-Layer Understanding of Cellular Responses to Ionizing Radiation
|
2009-2012
|
J. Bartek
|
38
|
|
FP6 EU
|
018652 CRESCENDO
|
Consortium for Research into
Nuclear Receptors in Development and Aging
|
2006-2011
|
P. Bartůněk
|
38
|
|
GSF
|
GA310/08/0878
|
The role
of the cells prion protein in erytroidnic differentiation
|
2008-2012
|
P. Bartůněk (co-investigator)
|
38
|
|
GSF
|
GA204/09/1905
|
Disp3: A
potential role in the self renewal and differentiation of neural stem
cells
|
2009-2012
|
P. Bartůněk
|
38
|
|
ME CR
|
LC06077
|
Center of Chemical Genetics
|
2006-2010
|
P. Bartůněk
|
38
|
|
GSF
|
P305/10/0953
|
New
regulators of megakaryocyte and erythroid lineage commitment
|
2010-2013
|
P. Bartůněk
|
38
|
|
GSF
|
GA204/09/0565
|
Role of RECQ5
DNA helicase in maintenance of genomic stability
|
2009-2013
|
P. Janščák
|
42
|
|
GSF
|
P305/10/0281
|
Role of
the Rothmund-Thomson syndrome gene product in maintenance of genomic
stability
|
2010-2014
|
P. Janščák
|
42
|
